Rottinghaus Scott T. (CIK 0001942407)

Latest company ownership

ENTA - ENANTA PHARMACEUTICALS INC

Role: Chief Medical Officer

Shares held

22,590

Last filed at

Dec 5, 2025

Confidence Score

46.9

2025Q4

Confidence Score History

2023Q3 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Dec 5, 2025	Dec 5, 2025	ENANTA PHARMACEUTICALS INC	Chief Medical Officer	Sell	46.3	-798	-3.53%	✗	$11.4K
Aug 8, 2025	Aug 8, 2025	ENANTA PHARMACEUTICALS INC	Chief Medical Officer	Sell	46.3	-2,217	-8.94%	✗	$15.5K
Feb 12, 2025	Feb 14, 2025	ENANTA PHARMACEUTICALS INC	Chief Medical Officer	Sell	91.3	+6,889	38.45%	✗	$16K
Dec 6, 2024	Dec 10, 2024	ENANTA PHARMACEUTICALS INC	Chief Medical Officer	Sell	47.5	-866	-4.61%	✗	$7K
Aug 8, 2023	Aug 9, 2024	ENANTA PHARMACEUTICALS INC	Chief Medical Officer	Sell	46.3	-2,933	-6.21%	✗	$43.9K
Jul 11, 2024	Jul 15, 2024	ENANTA PHARMACEUTICALS INC	Chief Medical Officer	Sell	20.0	-11,945	-15.05%	✓	$190.7K
Feb 12, 2024	Feb 14, 2024	ENANTA PHARMACEUTICALS INC	Chief Medical Officer	Sell	85.0	+1,821	6.88%	✗	$9.4K
Dec 5, 2023	Dec 6, 2023	ENANTA PHARMACEUTICALS INC	Sr. VP & CMO	Sell	47.5	-534	-1.98%	✗	$5.1K